acetylglucosamine has been researched along with Fatty Liver, Nonalcoholic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mima, A | 1 |
| Liu, J; Xiao, X; Xie, T; Xie, Z; Zhang, Q | 1 |
| Ameneiro, C; Bernardo, G; Bilbao, J; Bravo, S; Chantada-Vazquez, MDP; Crespo, J; Dieguez, C; Fernandez-Ramos, D; Fidalgo, M; Fondevila, MF; Frühbeck, G; Gonzalez-Rellan, MJ; Guallar, D; Heras, V; Iruzubieta, P; Lima, N; Lopitz-Otsoa, F; Martinez-Chantar, ML; Mato, JM; Millet, O; Nogueiras, R; Novoa, E; Parracho, T; Prevot, V; Rodriguez, A; Schwaninger, M; Senra, A; Varela-Rey, M | 1 |
| Aghajan, M; Amrutkar, M; Booten, SL; Borén, J; Cansby, E; Kulkarni, NM; Magnusson, E; Mahlapuu, M; Marschall, HU; Nuñez-Durán, E; Svensson, LT | 1 |
1 review(s) available for acetylglucosamine and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Emerging Role of Protein O-GlcNAcylation in Liver Metabolism: Implications for Diabetes and NAFLD.
Topics: Acetylglucosamine; Acylation; Diabetes Mellitus; Humans; N-Acetylglucosaminyltransferases; Non-alcoholic Fatty Liver Disease; Protein Processing, Post-Translational; Signal Transduction | 2023 |
3 other study(ies) available for acetylglucosamine and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Prediction of decreased estimated glomerular filtration rate using liver fibrosis markers: a renal biopsy-based study.
Topics: Acetylglucosamine; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Biopsy; Creatinine; Fibrosis; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Kidney; Liver Cirrhosis; Middle Aged; Nephrosclerosis; Non-alcoholic Fatty Liver Disease; Renal Insufficiency, Chronic; Risk Factors; Young Adult | 2022 |
Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial function.
Topics: Acetylglucosamine; Animals; Down-Regulation; Hepatocytes; Humans; Lipids; Mice; Mitochondria; Non-alcoholic Fatty Liver Disease | 2023 |
Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease.
Topics: Acetyl-CoA Carboxylase; Acetylglucosamine; Animals; Apoptosis; Body Weight; Diet, High-Fat; Gene Expression Regulation; Hepatocytes; Intracellular Signaling Peptides and Proteins; Lipogenesis; Liver; Macrophages; Male; Mice, Inbred C57BL; Mice, Obese; Mitochondria; Non-alcoholic Fatty Liver Disease; Oligonucleotides, Antisense; Organ Size; Oxidative Stress; Protein Serine-Threonine Kinases; RNA, Messenger | 2019 |